Health
Modulating immunometabolic processes to control lung infection – News-Medical.Net
When drugs to kill microbes are ineffective, host-directed therapy uses the body’s own immune system to deal with the infection.
Reviewed by Emily Henderson, B.Sc.Jul 23 2020
When drugs to kill microbes are ineffective, host-directed therapy uses the body’s own immune system to deal with the infection. This approach is being tested in patients with COVID-19, and now a team of researchers at Trinity College Dublin has published a study showing how it might also work in the fight against tuberculosis (TB). The findings are published in the journal Frontiers in Immunology today (Thursday 23rd July 2020).
Although the bacte…
Continue Reading
